US › Healthcare

Psyence Biomedical Ltd. Common Shares (PBM)

US · Healthcare · Biotechnology

$4.22-2.31%

Last close · 2026-10-16

Latest quarter · ended 2025-09-30

Revenue

Net profit

$-753,254

EPS

$-0.51

EPS estimate

$0.00

Key statistics

Market cap

$16.5M

Forward P/E

0.0

P/B

1.42

Book value

$7.39

EPS (TTM)

$-12.56

52-week high

$22.06

52-week low

$1.92

50-day MA

$4.80

200-day MA

$5.53

Beta

1.69

Shareholding

Insiders

2.97%

Institutions

13.24%

Largest institutional holders

Fund	Stake
Parallel Advisors, LLC	3.97%
AdvisorShares Investments, LLC	3.20%
Morgan Stanley - Brokerage Accounts	0.99%
Jane Street Group LLC	0.80%
XTX Topco Ltd	0.40%
Citadel Advisors Llc	0.31%
Stonehage Fleming Financial Services Holdings Ltd	0.00%
UBS Group AG	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Psyence Biomedical Ltd. Common Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.